Ramachandran N

[Ramachandran N @Dr_RamMD]

@JipmerNephro Thank you sir. I feel blessed. Thank you all for the heartwarming congratulations and wishes.

[Sreejith Parameswaran @SreejithDr]

Therapeutic targets in AS: New molecules are in the pipeline.
Ref: https://t.co/P3hIURDwIG
#ECNeph #Alport
4/10

[Sreejith Parameswaran @SreejithDr]

All disorders from abnormalities of collagen IV a345 molecule are classified as forms of #Alport syndrome
This will bring Thin Basement Memb Dx & Benign Familial hematuria & Female carriers of XLAS under #Alport syndrome
#ECNeph @myadla @arvindcanchi @ISNeducation
2/8

[ISN Education @ISNeducation]

7/n #ECNeph @SreejithDr @myadla
Alport Syndrome in Women and Girls https://t.co/WMT2ilCDur

[ISN Education @ISNeducation]

6/n Women and AS .. any different
Nephrologists think of AS as primarily affecting men.. twice as many women -affected by the XLAS
Affected women:commonly undiagnosed
15%–30% -> renal failure by 60 years and often hearing loss by middle age #ECNeph @myadla @SreejithDr

[Sreejith Parameswaran @SreejithDr]

https://t.co/Mz9wVVLkGy
#ECNeph @myadla @JipmerNephro
@Vidhya44582466 @Dr_RamMD @SwathyRaju @kapil_sejpal @SSMorkhandikar @challa_jaswanth @NaveenNephro
@dhanin2 @GangaRgnair @AnandhUrmila @anandthedoc @arvindcanchi

[Ramachandran N @Dr_RamMD]

Hello everyone, Ram here , from JIPMER #ECNeph

[Ramachandran N @Dr_RamMD]

@arvindcanchi @SreejithDr @fearingforties @myadla No sir.#ECNeph

[Ramachandran N @Dr_RamMD]

https://t.co/GuQYXw4qiy

#ECNeph

[Ramachandran N @Dr_RamMD]

@SreejithDr @kapil_sejpal @SwathyRaju @Vidhya44582466 @JipmerNephro Thank you sir..Good evening everyone.#ECNeph